Video Shorts

Why Early Commercialization Plans Are Crucial for Cell & Gene

Why Tox Studies are a Strategic Investment in Biotech

The Most Important Rule for R&D Investment

Why Great Science is No Longer Enough

1 Minute Fact: CMOs and Hybrids to Control 54% Share of Global Biologics Capacity

North Carolina: A Global Growing Life Sciences Hub?

The Biopharma Hiring Crisis: Why 36% of Facilities are Struggling

How Biotechs Can Accelerate Drug Development & Access Data Faster

Future Trends in Biologics & Global Supply Strategy

Can We Recreate Human Biology in a Lab?

Why 95% of Drug Discovery Fails_ The 'Large Mice' Problem

How AI is Revolutionizing Biopharmaceutical Manufacturing

Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring

AI is ALREADY Accelerating Drug Development Far Beyond Human Capacity

Why Testing Drug Packaging Leachables is Critical for Patient Safety

The strategic CRO relationship essential for PK regulatory readiness

Developing Stable Drug Products that Can Sustain Stress and Shaking

Top 10 Questions We Asked At CPHI

Trending in Bio/Pharma: AI, Gene Therapy, & More

What's the Big Deal with Mastering ADC Supply Chains?

How Digital Twins Predict Biomanufacturing Success

Why Particle Size Measurements With DLS Are Often Inaccurate

AI: Controlling the Process vs. Just Recommending

How to Industrialize AI for Hundreds of Drug Models

Revolutionizing Medicine with Organ-on-Chip Platforms

Why Quality Control Fails for Personalized Medicine

AI is the GPS of Enzyme Engineering

Manufacturing Vaccines Takes Decades of Expertise

Top Tips for Thriving at CPHI

How Cheese Tech is Revolutionizing Medicine Traceability